Dan Mendelson is President of Avalere Health. He leads the firm’s operations and engages in data-driven strategic work for major clients in life sciences, managed care, and the provider sectors. Prior to founding Avalere in 2000, Dan served as Associate Director for Health at the White House Office of Management and Budget. Mr. Mendelson presently serves on the Board of Champions Oncology (CSBR) and is Executive in Residence at the Fuqua School of Business at Duke University. He previously served on the boards of Coventry Healthcare (sold to Aetna in 2013), PharMerica Corporation (PMC), and HMS holdings (HMSY). Dan speaks frequently and is often quoted in the media on business strategy and policy matters–-often highlighting the outstanding analytic work of the Avalere staff. He has an MPP from the Kennedy School of Government at Harvard University and a BA in Economics and Viola Performance from Oberlin College.